Numb. | TREATMENT //carcinogen (if not AOM) and /mice (if not rats) | Category | Author, year (click name for abstract) | Potency on tumor incidence | Tumor percent inhibition | Cancer percent inhibition | Potency on tumor multiplic. | Protocol | blinded scoring | Ro- dents | carcinogen N x dose | weeks | Tum. in Contrl | No. of Contrl Rats | Tum. in treatd | No. of Treated Rats | Potency on tumor incidence | Carcin. in ctrl | Contrl rats | Carcin. in treatd | Treated rats | Cancer percent inhibition | Multiplic. in contrl | Multiplic. in treatd | Potency on tumor multiplic. | Agent (3 lett.) or comment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T263 | valspodar PGP-inhib 15mg/kg | other+ | Kankesan 06 | 1.18 | 15 | 63 | 2.0 | post | Rf' | dmh 100+PH | 35 | 22 | 24 | 14 | 18 | 1.18 | 18 | 24 | 5 | 18 | 63 | 2.00 | 1.00 | 2.0 | val |
To download data in Excel: select data (Ctrl-A), copy/paste (Ctrl-C) in an empty Excel page (Ctrl-V)